ArticleWorld journal of urology2025

TROP-2 overexpression in papillary renal cell carcinoma supports its potential as a therapeutic target for antibody-drug-conjugate therapy.

Carolina Kessler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.